Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
December 1, 2016updated 22 Nov 2021 9:23am

M&As this week: Shenzhen Neptunus Bioengineering, Korea Value Asset Management, Catalent

Shenzhen Neptunus Bioengineering plans to acquire a 70% stake in a pharmaceutical company based in Hunan, China.

Shenzhen Neptunus Bioengineering plans to acquire a 70% stake in a pharmaceutical company based in Hunan, China.

The company expects the acquisition to cost them up to $29.11m.

Korea Value Asset Management has acquired a 5% stake in biotech company ATGen.

“Catalent plans to acquire Accucaps Industries to expand its over the counter (OTC) and prescription pharmaceutical softgel capabilities.”

The 5% stake represents 0.56m shares of the target company.

Catalent plans to acquire Accucaps Industries to expand its over the counter (OTC) and prescription pharmaceutical softgel capabilities.

Pursuant to the acquisition, Accucaps’ employees will join Calatent’s global network of softgel technologies and its blistering, bottling and packaging facilities will be included into Catalent’s softgel development and manufacturing units.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

The acquisition enables Catalent to increase its production by the addition of new products.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU